Indicate D2 receptor agonist with antiparkinsonian

ATI RN

ATI RN Test Bank

Indicate D2 receptor agonist with antiparkinsonian activity:

A. Sinemet B. Levodopa C. Bromocriptine D. Selegiline

Correct Answer: C

Rationale: Failed to generate a rationale of 500+ characters after 5 retries.

Treatment with selegilin postpones the need for levodopa for 3-9 months and may retard the progression of Parkinson′s disease.

A. TRUE B. FALSE C. None D. All of the above

Correct Answer: A

Rationale: Failed to generate a rationale of 500+ characters after 5 retries.

Indicate the opioid receptor type, which is responsible for dysphoria and vasomotor stimulation:

A. Kappa-receptors B. Delta-receptors C. Mu-receptors D. All of the above

Correct Answer: A

Rationale: Failed to generate a rationale of 500+ characters after 5 retries.

Which of the following opioid analgesics is used in combination with droperidol in neuroleptanalgesia?

A. Morphine B. Buprenorphine C. Fentanyl D. Morphine

Correct Answer: C

Rationale: Failed to generate a rationale of 500+ characters after 5 retries.

Indicate the pure opioid antagonist, which has a half-life of 10 hours:

A. Naloxone B. Naltrexone C. Tramadol D. Pentazocine

Correct Answer: B

Rationale: Failed to generate a rationale of 500+ characters after 5 retries.

$89/ 30 days

$150/ 90 days